Neuhu+

In the latest Shot Callers episode, Mark Mastalir, Co-CEO of Halo Neuroscience, discusses insights on the company; subscribe to the FOS Daily newsletter for updates. 00:10:00

David Parker · CEO at Halo Security

In the latest Shot Callers episode, Mark Mastalir, Co-CEO of Halo Neuroscience, discusses insights on the company; subscribe to the FOS Daily newsletter for updates. 00:10:00

Recent Videos

Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold

Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited

Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4

Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci

Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7

Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma

Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health

EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics

Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG

Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience

Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2

Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals

4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd

4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd

4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

Recognizing the talent to build great companies|Glenn Solomon,Managing Partner,GGV Capital

The Investor Perspective- From Start to Scale' with Caryn Marooney|Chetan Puttagunta,investor,Benchmark

Mastering Alpha Creation: An Exclusive Conversation with Sunil Singhania, Founder of Abakkus Asset Management LLP on ICICI Direct

Unlocking Madagascar's Potential: High-Quality Graphite and Vanadium Projects

In his interview on "Mad Money" with Jim Cramer, Diebold Nixdorf CEO Octavio Marquez highlighted the company's strategic focus on integrating advanced technology to enhance the efficiency and security of banking and retail operations |Mr. Octavio Marquez

Investing in a New Age of Global Media|Shamin Rostami Walsh,Managing Director,BAM Ventures

Alaska Airlines CEO Ben Minicucci on Merger Talks and Gaining White House Approval | Ben Minicucci, CEO, Alaska Airlines .

We focus on well-being for people and the planet, work and purpose, and human connection|Andrew Parker,General Partner, Spero Ventures

Exploration Updates from Galen McNamara on Hughes and Mogion Projects

Can You Negotiate Auto Insurance Rates? Tips for Lowering Premiums

Optimizing Soil Pollution Management with Advanced Geostatistics and International Innovation

Izertis CEO Pablo Martín Prepares for Market Leap After Decade of Tenfold Growth | Pablo Martin, CEO, IZERTIS SA.

In the latest Shot Callers episode, Mark Mastalir, Co-CEO of Halo Neuroscience, discusses insights on the company; subscribe to the FOS Daily newsletter for updates. 00:10:00

Recent Videos

Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold

Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited

Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4

Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci

Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7

Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma

Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health

EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics

Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG

Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience

Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2

Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals

4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd

4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd

4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

Recognizing the talent to build great companies|Glenn Solomon,Managing Partner,GGV Capital

The Investor Perspective- From Start to Scale' with Caryn Marooney|Chetan Puttagunta,investor,Benchmark

Mastering Alpha Creation: An Exclusive Conversation with Sunil Singhania, Founder of Abakkus Asset Management LLP on ICICI Direct

Unlocking Madagascar's Potential: High-Quality Graphite and Vanadium Projects

In his interview on "Mad Money" with Jim Cramer, Diebold Nixdorf CEO Octavio Marquez highlighted the company's strategic focus on integrating advanced technology to enhance the efficiency and security of banking and retail operations​ |Mr. Octavio Marquez

Investing in a New Age of Global Media|Shamin Rostami Walsh,Managing Director,BAM Ventures

Alaska Airlines CEO Ben Minicucci on Merger Talks and Gaining White House Approval | Ben Minicucci, CEO, Alaska Airlines .

We focus on well-being for people and the planet, work and purpose, and human connection|Andrew Parker,General Partner, Spero Ventures

Exploration Updates from Galen McNamara on Hughes and Mogion Projects

Can You Negotiate Auto Insurance Rates? Tips for Lowering Premiums

Optimizing Soil Pollution Management with Advanced Geostatistics and International Innovation

Izertis CEO Pablo Martín Prepares for Market Leap After Decade of Tenfold Growth | Pablo Martin, CEO, IZERTIS SA.

In his interview on "Mad Money" with Jim Cramer, Diebold Nixdorf CEO Octavio Marquez highlighted the company's strategic focus on integrating advanced technology to enhance the efficiency and security of banking and retail operations |Mr. Octavio Marquez